JONES MITCHELL LAWRENCE (Chief Medical Officer) sold 35.6% of their position (51.88K shares) of PALISADE BIO, INC. on the open market
Open‑market sale worth $106.5K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/8/2026ACC: 0001493152-26-032561
Officer· Chief Medical Officer
Since Feb 2026
-51.88K
Net shares
Net seller
$106.5K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
131.17K acquired · 183.05K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+131.17K
Price / share
—
Trade value
—
% of position
891.0%
7/6/2026
14.72K→145.89K
Common Stock
Direct
Shares
−51.88K
Price / share
$2.05
Trade value
$106.54K
% of position
35.6%
7/7/2026
145.89K→94.01K
Total
Net shares
+79.29K
Net value
-$106.54K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/6/2026 | M · Option Exercise | +131.17K | — | — | 891.0% | 14.72K | 145.89K |
| Common Stock Direct | 7/7/2026 | S · Sale | −51.88K | $2.05 | $106.54K | 35.6% | 145.89K | 94.01K |
| Total | +79.29K | -$106.54K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
131.17K shares
Shares
−131.17K
Strike price
Held after
655.83K
Exercisable
—
7/6/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock131.17K shares | 7/6/2026 | M · Option Exercise | −131.17K | — | 655.83K |